Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6466 to 6480 of 7707 results

  1. Kidney transplantation (rejection) - everolimus [ID117]

    Discontinued [GID-TAG241]

    Technology appraisal guidance
    Discontinued

  2. Xpert MTB/RIF assay for the detection of active pulmonary tuberculosis and multi-drug resistant tuberculosis

    Discontinued [GID-DT9]

    Diagnostics guidance
    Discontinued

  3. Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (in combination with bevacizumab) [ID44]

    In development [GID-TAG388] Expected publication date: TBC

    Technology appraisal guidance
    In development

  4. Juvenile idiopathic arthritis - adalimumab [ID385]

    Discontinued [GID-TAG400]

    Technology appraisal guidance
    Discontinued

  5. Atrial fibrillation - clopidogrel (in combination with aspirin) [ID95]

    Discontinued [GID-TAG416]

    Technology appraisal guidance
    Discontinued

  6. Bempegaldesleukin with nivolumab for untreated unresectable or metastatic melanoma

    Discontinued [GID-TA10970]

    Technology appraisal guidance
    Discontinued

  7. Temozolomide for the treatment of advanced and metastatic melanoma [ID316]

    Discontinued [GID-TAG401]

    Technology appraisal guidance
    Discontinued

  8. Vandetanib for the second line treatment of non-small cell lung cancer [ID46]

    Discontinued [GID-TAG405]

    Technology appraisal guidance
    Discontinued

  9. Erlotinib in combination with bevacizumab for the maintenance treatment of advanced or metastatic non-small cell lung cancer [ID44]

    Discontinued [GID-TA11206]

    Technology appraisal guidance
    Discontinued

  10. Erlotinib in combination with bevacizumab for the second line treatment of advanced or metastatic non-small cell lung cancer [ID43]

    Discontinued [GID-TA11207]

    Technology appraisal guidance
    Discontinued

  11. Nivolumab for treating relapsed or refractory diffuse large B-cell lymphoma [ID986]

    Discontinued [GID-TA10140]

    Technology appraisal guidance
    Discontinued

  12. Eryaspase with chemotherapy for previously treated advanced or metastatic pancreatic cancer [ID3781]

    Discontinued [GID-TA10637]

    Technology appraisal guidance
    Discontinued

  13. Zio XT for detecting cardiac arrhythmias

    In development [GID-MT591] Expected publication date: TBC

    Medical technologies guidance
    In development

  14. Lifitegrast for treating dry eye disease [ID1229]

    Discontinued [GID-TA10196]

    Technology appraisal guidance
    Discontinued

  15. Avacopan for treating anti-neutrophil cytoplasmic antibody-associated vasculitis [ID1178]

    Discontinued [GID-TA10199]

    Technology appraisal guidance
    Discontinued